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Abstract
Background: Biological applications of nanoparticles are rapidly increasing, which introduces new possibilities to
improve the efficacy of radiotherapy. Here, we synthesized titanium peroxide nanoparticles (TiOxNPs) and investigated
their efficacy as novel agents that can potently enhance the effects of radiation in the treatment of pancreatic cancer.
Methods: TiOxNPs and polyacrylic acid-modified TiOxNPs (PAA-TiOxNPs) were synthesized from anatase-type titanium
dioxide nanoparticles (TiO2NPs). The size and morphology of the PAA-TiOxNPs was evaluated using transmission
electron microscopy and dynamic light scattering. The crystalline structures of the TiO2NPs and PAA-TiOxNPs with and
without X-ray irradiation were analyzed using X-ray absorption. The ability of TiOxNPs and PAA-TiOxNPs to produce
reactive oxygen species in response to X-ray irradiation was evaluated in a cell-free system and confirmed by flow
cytometric analysis in vitro. DNA damage after X-ray exposure with or without PAA-TiOxNPs was assessed by
immunohistochemical analysis of γ-H2AX foci formation in vitro and in vivo. Cytotoxicity was evaluated by a colony
forming assay in vitro. Xenografts were prepared using human pancreatic cancer MIAPaCa-2 cells and used to evaluate
the inhibition of tumor growth caused by X-ray exposure, PAA-TiOxNPs, and the combination of the two.
Results: The core structures of the PAA-TiOxNPs were found to be of the anatase type. The TiOxNPs and
PAA-TiOxNPs showed a distinct ability to produce hydroxyl radicals in response to X-ray irradiation in a dose- and
concentration-dependent manner, whereas the TiO2NPs did not. At the highest concentration of TiOxNPs, the amount
of hydroxyl radicals increased by >8.5-fold following treatment with 30 Gy of radiation. The absorption of PAA-TiOxNPs
enhanced DNA damage and resulted in higher cytotoxicity in response to X-ray irradiation in vitro. The
combination of the PAA-TiOxNPs and X-ray irradiation induced significantly stronger tumor growth inhibition
compared to treatment with either PAA-TiOxNPs or X-ray alone (p < 0.05). No apparent toxicity or weight loss was
observed for 43 days after irradiation.
Conclusions: TiOxNPs are potential agents for enhancing the effects of radiation on pancreatic cancer and act
via hydroxyl radical production; owing to this ability, they can be used for pancreatic cancer therapy in the future.
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Background
Pancreatic cancer is a highly lethal disease that is often
diagnosed only in the advanced stage. It is the fourth
most common cause of cancer-related deaths in the
United States, causing 40,560 deaths annually [1]. More-
over, the 5-year survival rate of pancreatic cancer patients
is approximately 3-7 % after diagnosis [1, 2]. Locally
advanced pancreatic cancer is also notoriously resist-
ant to many types of cytotoxic chemotherapy and
radiotherapy [3]. As a result, there are currently no
effective therapies for pancreatic cancer, and novel
strategies need to be explored.
The biological application of nanoparticles (NPs) is
rapidly increasing in nanotechnology and introduces
new possibilities for the diagnosis and treatment of human
cancers [4–6]. NPs have been used in many different areas
of radiation oncology, including radiosensitization [7].
Nano-sized titanium dioxide (TiO2) is one of the most
widely produced nanoparticles. TiO2 is poorly soluble
and has been used in numerous applications as a food
colorant, or as a white pigment in a number of products
including cosmetics, medicines, and pharmaceutical prod-
ucts [8, 9]. Rutile and anatase are the two major crystalline
forms of TiO2. The photocatalytic activity and cytotoxicity
of anatase TiO2 nanoparticles (TiO2NPs) are higher than
those of the rutile forms [10, 11]. Recently, TiO2NPs have
been used in the phototherapy of malignant cells and are
regarded as potential photosensitizing agents for photo-
dynamic therapy because they exert unique phototoxic ef-
fects upon ultraviolet (UV) irradiation [12–16]. Despite
the promising effects of UV-activated TiO2NPs, this strat-
egy seems to be ineffective in treating many cancers and is
difficult to apply clinically for two major reasons. First,
UV light cannot penetrate the human body to reach in-
ternal organs such as the gastrointestinal system, liver, and
pancreas, thus limiting the application of this technique to
superficial tumors [17]. Second, the UV-mediated produc-
tion of reactive oxygen species (ROS) occurs for a very
short duration and is insufficient to provide a continuous
and prolonged cancer-killing effect [18]. Radiotherapy
using X-rays is known to be effective in various cancer
treatments. However, to our knowledge, there are few re-
ports investigating whether or not TiO2NPs can enhance
the effects of X-ray irradiation [19]. In addition, the prop-
erties of TiO2NPs seem to be insufficient to render them
useful as radiosensitizers. Wang et al. demonstrated that
the potential biological effects of TiO2NPs depend on
their size, crystal phase, surface coating, and chemical
composition [20]. Therefore, certain modifications may be
necessary to make TiO2NPs suitable for use as agents that
enhance the effects of radiation.
Chemical reactions between hydrogen peroxide and
TiO2 have been widely investigated [21, 22], but the
effects of these reactions on the properties of TiO2NPs
in response to X-ray irradiation have not been clarified.
In this study, we investigated the properties of titanium
peroxide nanoparticles (TiOxNPs) to determine whether
the TiOxNPs might be useful as potential agents to en-
hance the effects of radiation against a human pancreatic
cancer model in vitro and in vivo.
Materials and methods
Preparation of TiOxNPs
TiOxNPs were synthesized from anatase-type TiO2NPs
according to several procedures that involve hydrogen
peroxide processing (Fig. 1a) [23]. For in vitro and in
vivo experiments, the surfaces were modified using poly-
acrylic acid (PAA) to prevent aggregation of the bare
TiOxNPs under physiological conditions [24]. The mater-
ial for the TiO2NPs (STS-01) was purchased from Ishihara
Sangyo, Ltd. (Osaka, Japan). Details of the syntheses of
TiOxNPs and PAA-TiOxNPs are shown in Additional file 1.
Transmission electron micrography (TEM), dynamic light
scattering (DLS), and X-ray absorption fine structure
(XAFS) analyses
The size and morphology of the PAA-TiOxNPs were
studied using a transmission electron microscope (JEM-
1200EX, JEOL Ltd., Tokyo, Japan) as described previ-
ously [25]. The transmission electron micrographs were
recorded at an acceleration voltage of 80 kV. DLS was
conducted using a Malvern Zetasizer Nano ZS to esti-
mate the hydrodynamic diameter of the PAA-TiOxNPs.
The XAFS measurements in fluorescence mode were
performed around a Ti K-edge energy region at BL9A at
the Photon Factory, KEK, Japan. Synchrotron radiation
from a 2.5 GeV storage ring was monochromatized using
a Si (111) double crystal monochromator modified to
2 × 1 mm2 with slits and counted using an ion chamber
for I0 and a Lytle-type detector for fluorescence X-rays.
Higher harmonic radiation was removed using an Rh-Ni-
coated mirror. The TiO2NP and PAA-TiOxNP suspen-
sions were put into polyethylene bags for the XAFS mea-
surements. TiO2 minerals (rutile and anatase) on Scotch
tape were measured as standard titanium materials with
known chemical compositions and crystal structures.
Cell culture and establishment of the animal models
The MIAPaCa-2 human pancreatic cancer cell line was
obtained from the American Type Culture Collection
(Rockville, MD, USA) and maintained in RPMI-1640
medium. Male BALB/c nude mice (body weight: 20–22 g)
were purchased from CLEA Corporation (Tokyo, Japan).
The nude mice were maintained in specific pathogen-
free animal care facilities under isothermal conditions
with regular photoperiods. All animal experiments were
approved by the Institutional Animal Care and Use Com-
mittee (Permission number: 100605R1) and performed
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according to Kobe University Animal Experimentation
Regulations.
X-ray irradiation
X-ray irradiation was performed using a MBR-1505R2
(Hitachi, Tokyo, Japan) at a voltage of 150 kV and a
current of 5 mA with a 1-mm-thick aluminum filter
(0.5 Gy/min at the target). Prior to each experiment,
the mice were anesthetized using an intraperitoneal
administration of somnopentyl (0.1 mg/g body weight)
and were then put to sleep under anesthesia and immobi-
lized in a customized harness that exposed the hind leg
while shielding the remainder of the body with lead during
irradiation.
ROS evaluation
Quantification of ROS generation from the NPs in re-
sponse to X-ray irradiation in a cell-free system was
performed using 3’-(p-aminophenyl) fluorescein (APF;
Sekisui Medical Co. Ltd., Tokyo, Japan), which fluoresces
mainly in response to hydroxyl radicals [26]. APF (5 μM)
was added to different concentrations of the suspensions
of TiOxNPs, PAA-TiOxNPs, and TiO2NPs prepared using
96-well plates. Each plate was then exposed to different
doses of X-ray radiation. The APF signal was measured
using a multi-well plate reader (Fluoroskan Ascent FL,
Thermo Fisher Scientific Inc., MA, USA) at excitation/
emission wavelengths of 490/515 nm. To determine
whether the increase in APF fluorescent signals was
Fig. 1 Characteristics of the PAA-TiOxNPs. a Scheme for the synthesis of the PAA-TiOxNPs from anatase TiO2NPs. b Representative TEM image of
the PAA-TiOxNPs. The size of the PAA-TiOxNPs was approximately 50 nm. c Size distribution of the PAA-TiOxNPs measured by DLS. d Structure of
TiO2NPs and PAA-TiOxNPs before and after X-ray irradiation, as determined by XAFS spectra
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caused by ROS generation, antioxidants such as vitamin C
(1 mM) or glutathione (1 mM) were added as ROS
scavengers. The amount of hydrogen peroxide was
measured in response to carboxy-2′, 7’-dichlorofluores-
cein (C-H2DCF; Molecular Probes, Inc., Eugene, OR,
USA). C-H2DCF (50 μM) was added to suspensions of
TiOxNPs, which were then exposed to X-ray radiation.
The fluorescent signal was measured at excitation/
emission wavelengths of 485/612 nm.
The production of intracellular ROS including hydrogen
peroxide, hydroxyl radicals, and superoxide anions was
evaluated using a fluorescence activated cell sorting (FACS
Calibur; Becton-Dickinson, NJ, USA). The MIAPaCa-2
cells were treated with 0.1 % w/v PAA-TiOxNPs for 1 h at
37 °C with or without 30 Gy X-ray irradiation. For 30 min,
the cells were stained with 10 μM APF, 50 μM C-H2DCF,
and 50 ng/mL hydroethidium (HE; Molecular Probes,
Inc., OR, USA) per sample to detect cellular hydroxyl
radicals, hydrogen peroxide, and superoxide anions,
respectively [27].
Detection of DNA damage and colony forming assay
in vitro
Induction of deoxyribonucleic acid (DNA) damage
was investigated by the detection of phosphorylated
histone 2AX (γ-H2AX) foci using immunocytochemistry.
MIAPaCa-2 cells were subcultured on 35-mm dishes. The
cells were treated with 0.15 % w/v PAA-TiOxNPs for 1 h
and/or 5 Gy of X-ray irradiation. After the treatment, the
cells were fixed in 4 % paraformaldehyde in phosphate
buffered saline (PBS) for 20 min, permeabilized with 0.1 %
Triton X-100 in PBS for 5 min, and blocked in 5 % bovine
serum albumin in PBS for 60 min. Cells were incubated
with 1:200 rabbit anti γ-H2AX antibody (Cell Signaling
Technology, MA, US) overnight at 4 °C. Then, the cells
were incubated with 1:20 tetramethyl rhodamine isothio-
cyanate (TRITC)-conjugated anti-rabbit secondary anti-
body (Dako, Glostrup, Denmark) for 90 min at room
temperature. Cell nuclei were stained with 4’, 6-diaidino-2-
phenylindole (DAPI). Stained cells were observed using a
fluorescence microscope (BZ-9000, KEYENCE, Osaka,
Japan). Cells expressing nuclear γ-H2AX foci were then
counted manually from 100 cells for each treatment, and
the data were presented as the mean ± standard deviation
(SD) from 3 fields for each section [28].
To evaluate whether the PAA-TiOxNPs might en-
hance the effects of radiation in vitro, a colony forming
assay was performed. MIAPaCa-2 cells (1 × 106) were ex-
posed to 0.15 % w/v PAA-TiOxNPs for 30 min, and then
they were treated with 0, 3, or 5 Gy of X-ray irradiation.
The treated cells were counted and replated onto a new
10-cm tissue culture dish with fresh medium not con-
taining PAA-TiOxNPs. The cells were incubated for
10 days until the cell population completed colony
formation. After fixing and staining, colonies consisting
of more than 50 cells were counted and the surviving
fractions were calculated based on the survival of non-
irradiated cells.
Tumor growth inhibition of PAA-TiOxNPs combined with
X-ray radiation
MIAPaCa-2 cells (2 × 106) were injected subcutaneously
into the hind legs of the BALB/c nude mice as described
previously [29]. The tumor was expected to enlarge to
be palpable, i.e., approximately 6–10 mm in the longest
axis and 5–7 mm in the shortest axis, with skin thick-
ness by 7 days post injection. Tumor volume was calcu-
lated using the formula L ×W2/2, where L is the longest
axis and W is the shortest axis of the tumor. Using this
formula, the tumor volume was approximately 100–
200 mm3 on the treatment day. The mice were stratified
into 4 subgroups consisting of 3 mice each: untreated,
PAA-TiOxNPs alone, X-rays alone, and X-rays combined
with PAA-TiOxNPs. The mice were given an intra-
tumoral injection of 150 μL of an 8.7 % w/v PAA-
TiOxNP suspension with or without a single dose of
5 Gy of X-ray irradiation approximately 1 h after the in-
jection. To inject a sufficient amount of the PAA-
TiOxNP suspension while keeping the suspension as
homogeneous as possible, we injected 150 μL of the
PAA-TiOxNP suspension into each tumor. The tumor
size, body weight, and health of the mice were measured
for 43 days after the initial treatment (for a total of
50 days after the injection) [30].
Mechanism of tumor growth inhibitory effect by PAA-
TiOxNPs combined with X-ray irradiation
At 24 h after treatment, the tumors were excised, fixed
in 10 % formalin, and embedded in paraffin sections
(4-μm-thick). The samples were stained using hematoxylin
and eosin (H-E).
Induction and maintenance of DNA damage in the
tumor by X-ray radiation with or without PAA-TiOxNPs
was evaluated by detection of γ-H2AX immunoreactivity
using a fluorescence microscope (BZ-9000, Keyence,
Osaka, Japan). Sections were counterstained with DAPI.
Positive γ-H2AX signals in the nucleus were visually
counted in 300 cells for each treatment. The number of
γ-H2AX foci was calculated by averaging the number of
the positive cells from 3 fields for each section. Induc-
tion of apoptosis was also evaluated using the terminal
deoxynucleotidyl transferase-mediated deoxyuridine
triphosphate nick end labeling (TUNEL) assay (Roche
Applied Science, Indianapolis, IN, US) [31]. Positive
TUNEL signals were evaluated in 100 cells for each treat-
ment, and the number of apoptotic cells was calculated by
averaging the number of positive TUNEL signals from 6
fields for each section.
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Statistical analysis
Data are expressed as the mean ± SD. Comparisons
were performed using Student’s t-test, and differences
were considered significant at the 95 % confidence
level (p < 0.05).
Results
Successful preparation of TiOxNPs
Considering the enhanced permeability and retention
effect, we aimed to prepare nanoparticles with a size
of less than 100 nm. The PAA-TiOxNPs were found
to be approximately 50–70 nm in diameter, as determined
using TEM (Fig. 1b). Consistent with the TEM images,
the size of the PAA-TiOxNPs, as determined using DLS,
was approximately 50–100 nm with a narrow unimodal
size distribution (Fig. 1c).
The crystalline structures of TiO2NPs and PAA-
TiOxNPs with or without X-ray radiation (16 Gy)
were analyzed using XAFS (Fig. 1d). No change in
the coordination environment was observed around
the Ti ion from the original anatase-type TiO2NPs
until the PAA-TiOxNPs were irradiated with X-rays.
From this observation, it was concluded that the PAA-
TiOxNPs preserve the anatase structure of TiO2NPs in
the core structures.
ROS-generating effect of TiOxNPs under X-ray irradiation
The amount of hydroxyl radicals increased in a radiation
dose- and nanoparticle concentration-dependent man-
ner in the TiOxNPs and PAA-TiOxNPs, whereas no in-
crease in hydroxyl radical levels was observed in the
TiO2NPs (Fig. 2a). At the highest concentration of
TiOxNPs and PAA-TiOxNPs, the amount of hydroxyl
radicals with 30 Gy of radiation increased by more than
8.5 and 3.7 fold, respectively. The ROS-generating effect
using bare TiOxNPs appeared to be stronger than that
of PAA-TiOxNPs. ROS production was also confirmed
using antioxidants such as vitamin C and glutathione.
When these antioxidants were added to the TiOxNP
suspension, the APF signal did not increase, even with a
radiation dose of 30 Gy (Fig. 2b). Thus, the TiOxNPs
could produce large amounts of hydroxyl radicals under
X-ray irradiation. On the contrary, hydrogen peroxide
production from the TiOxNPs did not increase under
X-ray irradiation (Fig. 2c).
To assess intracellular ROS production by PAA-
TiOxNPs with X-ray radiation, the amount of hydroxyl
radicals, hydrogen peroxide, and superoxide anions was
measured using FACS. In cells treated with PAA-
TiOxNPs combined with X-ray radiation, the hydroxyl
radical levels increased by more than 2 fold and the
hydrogen peroxide levels increased by more than 1.6 fold
in comparison to the control, whereas the superoxide
levels did not increase (Fig. 2d).
Cytotoxic effects of PAA-TiOxNPs under X-ray irradiation
in vitro
First, intracellular absorption of PAA-TiOxNPs in
MIAPaCa-2 cells was directly confirmed by TEM
(Fig. 3a). Next, DNA damage induced by X-ray irradi-
ation with or without PAA-TiOxNPs was quantified with
regard to γ-H2AX foci formation. Compared to X-ray
irradiation alone, combination with PAA-TiOxNPs in-
duced a higher proportion of γ-H2AX foci (p < 0.05,
Fig. 3b, c). The effect of the combination of PAA-
TiOxNPs and X-ray irradiation evaluated by a colony
forming assay was significantly better than that of X-
rays alone (p < 0.05, Fig. 3d). Overall, the PAA-
TiOxNPs enhanced the cytotoxic effect of X-ray irradi-
ation in vitro.
Tumor growth inhibitory effects of PAA-TiOxNPs
combined with X-ray irradiation in vivo
The tumor growth inhibition in the group receiving both
the PAA-TiOxNPs and X-ray treatments was signifi-
cantly greater than that in the groups that received a
single treatment or in the untreated subgroups at
43 days after the initial treatment (p < 0.05, Fig. 4a, b).
The tumor volume in the mice treated with PAA-
TiOxNPs and X-rays was 35.4 % of that in mice treated
with X-rays alone. Thus, the PAA-TiOxNPs in com-
bination with X-ray radiation had synergistic cytotoxic
effects in vivo.
No immediate toxic reaction was observed in the
mice injected with the PAA-TiOxNPs. No mice died dur-
ing the 43-day observation period and none showed any
apparent loss of body weight (Fig. 4c). These findings sug-
gest that the PAA-TiOxNPs themselves do not have any
apparent toxicity at the effective dose applied during this
period.
Mechanisms underlying tumor growth inhibitory effects
in vivo
The localization of the injected PAA-TiOxNPs was evalu-
ated histologically. In H-E stained sections, PAA-TiOxNPs
were observed as brown dots (Fig. 5a). The brown dots in-
dicating aggregated PAA-TiOxNPs were observed inside
the tumor cells. Immunoreactivity of γ-H2AX indicating
occurrence and maintenance of DNA damage in the
tumor specimen was evaluated. The PAA-TiOxNPs com-
bined with X-ray irradiation induced significantly higher
numbers of positive cells compared to PAA-TiOxNPs or
X-ray irradiation alone (p < 0.05, Fig. 5b, c). The number
of TUNEL-positive cells was also significantly higher
in the combination group than in the single treatment
or untreated subgroups (p < 0.05, Fig. 5d, e). These
findings indicate that the PAA-TiOxNPs enhanced the
cytotoxicity of X-ray radiation through DNA damage
and induction of apoptosis.
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Discussion
To our knowledge, this is the first report to show that
TiOxNPs synthesized from anatase-type TiO2NPs can
produce hydroxyl radicals under X-ray irradiation. This
property resulted in remarkable tumor growth inhibition
in a human pancreatic carcinoma xenograft.
The core of the PAA-TiOxNPs remained the same as
that of TiO2NPs with the original anatase structure
(Fig. 1d), whereas the property of the TiOxNPs to pro-
duce ROS in response to X-ray irradiation was different
from that of TiO2NPs (Fig. 2a). Based on these findings




Fig. 2 ROS production by the TiOxNPs, PAA-TiOxNPs, and TiO2NPs under X-ray irradiation. a APF intensity indicating that hydroxyl radical production
in the TiOxNPs and the PAA-TiOxNPs increased in a radiation dose-dependent manner, but that of the TiO2NPs did not. Irradiated radiation doses were
0, 5, 10, and 30 Gy. Data are shown as the mean ± SD from 5 independent experiments. b Production and scavenging of ROS by 1 mM vitamin C
(Vit. C) or 1 mM glutathione (GSH). Histograms show mean ± SD calculated from 5 independent experiments. c Hydrogen peroxide production from
the TiOxNPs under X-ray irradiation. d Detection of intracellular ROS production by FACS. Mean fluorescence values are shown in each figure
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TiOxNPs, it was speculated that surface of the TiOxNPs
was different from that of TiO2NPs, and it seemed to be
peroxidized by hydrogen peroxide. The acquired property
of the TiOxNPs was first examined under cell-free condi-
tions (only water and TiOxNPs) using APF. Because the
APF reaction is specific to hydroxyl radicals, peroxynitrite
anion, and hypochlorite anion [26], the major ROS gener-
ated from the TiOxNPs and PAA-TiOxNPs in response to
X-ray irradiation was identified as hydroxyl radicals. Next,
this finding was further investigated in cells using FACS
(Fig. 2d). The results indicated that the hydroxyl radical
and hydrogen peroxide levels increased, whereas the levels
of superoxide anions did not. These results were consist-
ent with those observed in the cell-free system. Cellular
redox homeostasis is maintained by the balance between
the generation and elimination of ROS. Exogenous agents
that increase ROS generation or decrease antioxidant cap-
acity will shift the redox balance and result in an overall
increase in the ROS levels, which may induce cell death
when above a cellular tolerability threshold [32]. Cancer
cells would be more dependent on the antioxidant system





Fig. 3 PAA-TiOxNPs enhanced the effects of radiation in vitro. a TEM images showing PAA-TiOxNPs within the MIAPaCa-2 cells (red arrows).
b, c DNA damage illustrated by immunohistochemistry of γ-H2AX foci in the nucleus. The X-ray irradiation combined with PAA-TiOxNPs
induced a higher proportion of γ-H2AX foci-positive cells compared to the single treatment of X-ray irradiation or PAA-TiOxNPs. Data are
shown as the mean ± SD. *p < 0.05. d Significantly higher combination effects of X-ray irradiation with PAA-TiOxNPs were observed in a
colony forming assay. Data are shown as the mean ± SD from 3 independent experiments. *p < 0.05
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exogenous ROS-generating agents or compounds that
inhibit the antioxidant system. Combinations of ROS-
generating agents with X-ray radiation, which is capable of
abrogating cellular antioxidant systems, are likely to have
an additive or synergistic cytotoxic effect. From our deter-
mination that the combination of X-ray irradiation and
PAA-TiOxNPs induced higher amounts of ROS and DNA
damage in vitro, it was at least speculated that the PAA-
TiOxNPs might act as ROS-generating agents in response
to X-ray irradiation in the cells. The mechanism might
affect the combination effect observed in the colony form-
ing assay (Fig. 3d).
It was noteworthy that the use of PAA-TiOxNPs in
combination with X-ray radiation induced tumor growth
inhibition in vivo. The effect of the combination therapy
was significantly greater than that of each of the single
treatments (Fig. 4a, b), thus indicating a potential syner-
gistic effect. However, although our results indicate a po-
tential role for the production of hydroxyl radicals from
the PAA-TiOxNPs, the sites for ROS production (inside
the cells, or on the outer membrane, or both) remain un-
clear. In the histochemical analyses, the PAA-TiOxNPs
appeared to accumulate inside the cells (Fig. 5a), thus sug-
gesting that the increase in ROS levels according to the
Fenton reaction may occur inside the cells. Halliwell et al.
previously reported that the hydroxyl radical could be pro-
duced via the Fenton reaction in the presence of biological
free iron and superoxide, leading to oxidative damage
[33]. In our experimental setting, a small radiation dose
(5 Gy) was effective for induction of apoptosis and tumor
shrinkage; larger doses or multiple doses will probably
have greater effects. The use of the combination of
PAA-TiOxNPs with X-ray radiation in vivo appeared
to be effective for inhibiting tumor growth.
Metal nanoparticles have unique characteristics such
as particle size, high surface-to-volume ratio, broad op-
tical properties, and facile surface chemistry [34, 35].
Radiosensitization of gold nanoparticles (GNPs) occurs
because of the high absorbance of gold and the resulting
deposition of energy in surrounding tissues from photo-
electrons and auger electrons, and because of the gener-
ation of ROS [36–39]. Compared to these findings for
GNPs, fewer data appear to be available for the applica-
tions of TiOxNPs, and multiple aspects of TiOxNPs still
need to be evaluated. Although our results indicate that
TiOxNPs have potential for use as agents that enhance
the effects of radiation, further research on this property
of TiOxNPs in comparison to GNPs is necessary.
Our study has a few limitations. The route of adminis-
tration was intra-tumoral injection, and the effects of
intravenous injection were not tested. There are several
reports indicating that intravenously injected GNPs can
readily extravasate into advanced brain tumors, leading
to increased survival of mice with advanced glioblastoma
B C
A
Fig. 4 Tumor growth-inhibitory effects of PAA-TiOxNPs combined with X-ray radiation. a Tumor appearance in the xenografts for each treatment
after 43 days (arrowhead). b Changes in tumor size after each treatment. Each group consisted of 3 mice. Data are shown as the mean ± SD.
*p < 0.05. c Body weight changes after each treatment
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treated with radiotherapy plus GNPs [40, 41]. Therefore,
systemic intravenous administration of PAA-TiOxNPs
may induce an additional effect. Further evaluation is
warranted in this regard. On the contrary, some studies
have reported protracted elimination of GNPs from the
liver [42, 43], and other studies have reported the
nephrotoxicity of GNPs [44, 45]. Although no change in
the weight of the mice was observed in our experimental
setting, larger amounts of PAA-TiOxNPs seem to be ne-
cessary in case of systemic administration, and toxicity,
including acute liver or renal toxicity, will need to be
carefully evaluated.
Conclusions
In conclusion, TiOxNPs showed remarkable ROS pro-
duction upon X-ray irradiation. PAA-TiOxNPs were ef-
fective in a mouse model using engrafted human
pancreatic cancer cells. Although future studies will be
required to confirm the therapeutic effects and potential
toxicity of nanoparticles, our study shows that TiOxNPs
are promising agents for enhancing the effects of radi-
ation in pancreatic cancer therapy.
Additional file
Additional file 1: Details of the synthetic protocol for PAA-TiOxNPs
formation from TiO2NPs. (PPTX 151 kb)
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Fig. 5 Detection of DNA damage and of apoptosis induced by X-ray irradiation, the PAA-TiOxNPs, and their combination in vivo. a Localization of
the PAA-TiOxNPs (as visualized using H-E staining). Brown dots indicate accumulation of the PAA-TiOxNPs (yellow arrows). b Detection of DNA
damage by staining of γ-H2AX and DAPI in MIAPaCa-2 cells. c The number of γ-H2AX foci with the combination treatment was significantly
higher than that with the single treatment. Data are shown as the mean ± SD. *p < 0.05. d Induction of apoptosis and its evaluation by TUNEL
assay. e The number of apoptotic cells with the combination treatment was significantly higher than that with the single treatment. Data are
shown as the mean ± SD. *p < 0.05
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